About this FactMed analysis covering adverse side effect reports of AEB071 patients who developed HYPERGLYCAEMIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking AEB071 reported HYPERGLYCAEMIA to the FDA. A total of 37 AEB071 drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AEB071 and HYPERGLYCAEMIA. In doing so, we compare AEB071 with other drugs that cause HYPERGLYCAEMIA, to help you evaluate whether or not AEB071 causes HYPERGLYCAEMIA. Likewise, this page shows the most highly-reported side effects of AEB071, so you can see if HYPERGLYCAEMIA ranks among AEB071's most well-known side effects.
Summary Statistics
Reports of AEB071 causing HYPERGLYCAEMIA: 1
Reports of any side effect of AEB071 : 37
Percentage of AEB071 patients where HYPERGLYCAEMIA is a reported side effect: 2.7027%

FDA reports of any drug causing HYPERGLYCAEMIA : 14689
Average percentage for all medicated patients where HYPERGLYCAEMIA is reported as a complication: 0.0921%

Physician opinion on AEB071 as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AEB071:
RENAL TRANSPLANT ( 34 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPERGLYCAEMIA:

SEROQUEL (5930 patients)
LANTUS (2822 patients)
ZYPREXA (2101 patients)
ASPIRIN (1485 patients)
FOSAMAX (1271 patients)
RISPERDAL (966 patients)
HUMALOG (924 patients)
LASIX (922 patients)
HEPARIN SODIUM INJECTION (876 patients)
PREDNISONE (869 patients)
VIOXX (782 patients)
METFORMIN HCL (752 patients)
DEXAMETHASONE (734 patients)
LIPITOR (698 patients)
INSULIN (691 patients)
LISINOPRIL (644 patients)
FUROSEMIDE (562 patients)
AMBIEN (543 patients)
ZOMETA (535 patients)
NEURONTIN (527 patients)
SYNTHROID (502 patients)
SIMVASTATIN (500 patients)
ATENOLOL (484 patients)
NORVASC (462 patients)
ZOCOR (459 patients)
DECADRON (456 patients)
HYDROCHLOROTHIAZIDE (456 patients)
ZOLOFT (451 patients)
PROTONIX (446 patients)
COUMADIN (436 patients)
NEXIUM (428 patients)
XANAX (427 patients)
PAXIL (425 patients)
ABILIFY (419 patients)
GLYBURIDE (415 patients)
PREDNISOLONE (410 patients)
DEPAKOTE (393 patients)
OMEPRAZOLE (386 patients)
ATIVAN (386 patients)
ALBUTEROL (385 patients)
REVLIMID (376 patients)
PRILOSEC (375 patients)
PLAVIX (374 patients)
ACETAMINOPHEN (371 patients)
METHOTREXATE (369 patients)
GLUCOPHAGE (364 patients)
DIGOXIN (363 patients)
LORAZEPAM (357 patients)
AMARYL (351 patients)
NOVOLOG (350 patients)
AREDIA (345 patients)
PROZAC (343 patients)
BYETTA (339 patients)
POTASSIUM CHLORIDE (339 patients)
PREDNISONE TAB (331 patients)
GEODON (329 patients)
LEXAPRO (328 patients)
DIOVAN (321 patients)
ALLOPURINOL (318 patients)
CLONAZEPAM (316 patients)
CELEXA (313 patients)
ACCUTANE (311 patients)
TRAZODONE HCL (306 patients)
METFORMIN (305 patients)
ACTOS (302 patients)
PREVACID (300 patients)
EFFEXOR (292 patients)
CYMBALTA (289 patients)
ZOFRAN (280 patients)
WELLBUTRIN (278 patients)
TOPROL-XL (273 patients)
TEQUIN (273 patients)
AVANDIA (271 patients)
VELCADE (259 patients)
HALDOL (258 patients)
METOPROLOL TARTRATE (258 patients)
OXYCONTIN (257 patients)
LEVOTHYROXINE SODIUM (257 patients)
NOVORAPID (250 patients)
LYRICA (248 patients)
HUMULIN R (247 patients)
IBUPROFEN (243 patients)
GABAPENTIN (241 patients)
CYCLOPHOSPHAMIDE (238 patients)
AFINITOR (234 patients)
ALPRAZOLAM (233 patients)
AMLODIPINE (232 patients)
SPIRONOLACTONE (231 patients)
FOLIC ACID (230 patients)
CISPLATIN (230 patients)
PERCOCET (230 patients)
GLIPIZIDE (228 patients)
SOLOSTAR (228 patients)
COMPAZINE (223 patients)
COREG (220 patients)
CRESTOR (218 patients)
THALIDOMIDE (217 patients)
LEVAQUIN (216 patients)
APIDRA (215 patients)
METHYLPREDNISOLONE (215 patients)
ALTACE (207 patients)
SANDOSTATIN LAR (207 patients)
KLONOPIN (207 patients)
VICODIN (207 patients)
MORPHINE (203 patients)
OXYCODONE HCL (202 patients)
METOPROLOL (199 patients)
DIFLUCAN (198 patients)
ADVAIR DISKUS 100/50 (194 patients)
HUMULIN N (194 patients)
PREMARIN (191 patients)
SOLU-MEDROL (191 patients)
ACYCLOVIR (191 patients)
HUMALOG MIX 75/25 (190 patients)
CLOZARIL (190 patients)
TACROLIMUS (190 patients)
LORTAB (189 patients)
REMERON (189 patients)
LOPRESSOR (188 patients)
COLACE (187 patients)
ENALAPRIL MALEATE (183 patients)
CYCLOSPORINE (182 patients)
RANITIDINE (180 patients)
COZAAR (180 patients)
RAMIPRIL (179 patients)
CELEBREX (179 patients)
SINGULAIR (177 patients)
WARFARIN SODIUM (177 patients)
NITROGLYCERIN (176 patients)
VINCRISTINE (175 patients)
DEXAMETHASONE TAB (174 patients)
ZANTAC (173 patients)
REGLAN (173 patients)
FLEXERIL (171 patients)
VANCOMYCIN (170 patients)
LEVEMIR (170 patients)
PEPCID (169 patients)
CIPROFLOXACIN (169 patients)
LITHIUM CARBONATE (165 patients)
DOCETAXEL (165 patients)
VALIUM (163 patients)
LOVENOX (163 patients)
JANUVIA (162 patients)
ZETIA (159 patients)
CYTARABINE (158 patients)
BENADRYL (158 patients)
TYLENOL (CAPLET) (157 patients)
FAMOTIDINE (154 patients)
BACTRIM (154 patients)
RISPERIDONE (153 patients)
HEPARIN (153 patients)
ALDACTONE (153 patients)
PROGRAF (152 patients)
FLUOROURACIL (149 patients)
AMOXICILLIN (147 patients)
MIRTAZAPINE (147 patients)
LANSOPRAZOLE (147 patients)
EFFEXOR XR (145 patients)
MYCOPHENOLATE MOFETIL (145 patients)
METOCLOPRAMIDE (144 patients)
FLUCONAZOLE (143 patients)
CLONIDINE (143 patients)
OPTICLIK (143 patients)
TRICOR (142 patients)
CARBOPLATIN (142 patients)
ONDANSETRON (141 patients)
MULTI-VITAMINS (141 patients)
THORAZINE (141 patients)
ELAVIL (140 patients)
TOPAMAX (139 patients)
DIANEAL (139 patients)
ZYRTEC (138 patients)
PERIDEX (138 patients)
DIAZEPAM (138 patients)
SODIUM CHLORIDE (136 patients)
NYSTATIN (135 patients)
METFORMIN HYDROCHLORIDE (135 patients)
INSULIN GLARGINE (133 patients)
CARVEDILOL (132 patients)
TYLENOL (132 patients)
HUMULIN 70/30 (130 patients)
RESTORIL (129 patients)
FLONASE (129 patients)
CLINDAMYCIN (129 patients)
REMICADE (128 patients)
ZESTRIL (127 patients)
KEFLEX (126 patients)
NIFEDIPINE (125 patients)
TEMAZEPAM (125 patients)
ALENDRONATE SODIUM (125 patients)
FLAGYL (124 patients)
VITAMIN D (124 patients)
OPTIPEN (INSULIN PUMP) (124 patients)
TRAMADOL HCL (123 patients)
ALL OTHER THERAPEUTIC PRODUCTS (122 patients)
TEGRETOL (122 patients)
NAPROXEN (120 patients)
DILAUDID (120 patients)
FENTANYL (120 patients)
PACLITAXEL (118 patients)
DURAGESIC-100 (117 patients)
AMITRIPTYLINE HCL (117 patients)
RADIATION THERAPY (117 patients)
BEVACIZUMAB (116 patients)
LAMICTAL (116 patients)
MORPHINE SULFATE (114 patients)
GLIMEPIRIDE (114 patients)
GATIFLOXACIN (113 patients)
NOVOLIN R (113 patients)
FLOMAX (113 patients)
Most common side effects for patients taking AEB071:
VOMITING (6 patients)
NEPHROTIC SYNDROME (5 patients)
PROTEINURIA (5 patients)
ANOREXIA (4 patients)
ASTHENIA (4 patients)
DIZZINESS (4 patients)
FUNGAL OESOPHAGITIS (4 patients)
GASTRIC ULCER HAEMORRHAGE (4 patients)
GASTRITIS (4 patients)
KIDNEY TRANSPLANT REJECTION (4 patients)
NAUSEA (4 patients)
REFLUX OESOPHAGITIS (4 patients)
DIARRHOEA (3 patients)
DRUG INEFFECTIVE (3 patients)
ELECTROCARDIOGRAM QT PROLONGED (3 patients)
FEELING ABNORMAL (3 patients)
GLOMERULONEPHRITIS (3 patients)
HAEMOGLOBIN DECREASED (3 patients)
INCISION SITE PAIN (3 patients)
INSOMNIA (3 patients)
POST PROCEDURAL HAEMATOMA (3 patients)
PULMONARY EMBOLISM (3 patients)
ANURIA (2 patients)
BLOOD ALBUMIN DECREASED (2 patients)
CONSTIPATION (2 patients)
COUGH (2 patients)
DRUG INTERACTION (2 patients)
EAR PAIN (2 patients)
FATIGUE (2 patients)
FEBRILE NEUTROPENIA (2 patients)
GASTROENTERITIS (2 patients)
GASTROINTESTINAL INFECTION (2 patients)
HIATUS HERNIA (2 patients)
HYPOTENSION (2 patients)
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED (2 patients)
INFECTION (2 patients)
NASAL CONGESTION (2 patients)
PHARYNGOLARYNGEAL PAIN (2 patients)
PNEUMOCOCCAL SEPSIS (2 patients)
PNEUMONIA (2 patients)
POST PROCEDURAL HAEMORRHAGE (2 patients)
PSEUDOMONAS INFECTION (2 patients)
PYREXIA (2 patients)
RENAL IMPAIRMENT (2 patients)
UPPER-AIRWAY COUGH SYNDROME (2 patients)
URINARY TRACT INFECTION (2 patients)
URINOMA (2 patients)
ABDOMINAL PAIN (1 patients)
AGEUSIA (1 patients)
ANAEMIA (1 patients)
BACTERIAL INFECTION (1 patients)
BLADDER CATHETER REMOVAL (1 patients)
BLADDER CATHETERISATION (1 patients)
BLADDER OPERATION (1 patients)
BLOOD POTASSIUM DECREASED (1 patients)
BLOOD POTASSIUM INCREASED (1 patients)
COAGULOPATHY (1 patients)
CYSTOSTOMY (1 patients)
DEATH (1 patients)
DECREASED APPETITE (1 patients)
DEHYDRATION (1 patients)
DYSLIPIDAEMIA (1 patients)
DYSPEPSIA (1 patients)
DYSPNOEA (1 patients)
ELECTROCARDIOGRAM ABNORMAL (1 patients)
FALL (1 patients)
GASTROINTESTINAL HAEMORRHAGE (1 patients)
HAEMORRHOIDS (1 patients)
HEPATIC FUNCTION ABNORMAL (1 patients)
HYPERCALCAEMIA (1 patients)
HYPERGLYCAEMIA (1 patients)
HYPOXIA (1 patients)
INFLAMMATION (1 patients)
INTERNATIONAL NORMALISED RATIO DECREASED (1 patients)
KIDNEY FIBROSIS (1 patients)
LYMPHATIC FISTULA (1 patients)
LYMPHOCELE (1 patients)
OCCULT BLOOD POSITIVE (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PROTEIN TOTAL DECREASED (1 patients)
PROTHROMBIN TIME PROLONGED (1 patients)
PYELONEPHRITIS (1 patients)
RECTAL HAEMORRHAGE (1 patients)
RENAL ATROPHY (1 patients)
RENAL FAILURE ACUTE (1 patients)
RENAL TUBULAR NECROSIS (1 patients)
SCROTAL OEDEMA (1 patients)
SEPSIS (1 patients)
SEPTIC SHOCK (1 patients)
SHOCK HAEMORRHAGIC (1 patients)
SKIN LESION (1 patients)
SURGERY (1 patients)
TACHYCARDIA (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
URETHRAL DILATATION (1 patients)
URETHRAL OPERATION (1 patients)
URETHRAL STENOSIS (1 patients)
URINARY TRACT INFECTION PSEUDOMONAL (1 patients)
UROSTOMY (1 patients)
VESICOURETERAL REFLUX SURGERY (1 patients)
WEIGHT DECREASED (1 patients)
WEIGHT INCREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AEB071


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPERGLYCAEMIA and AEB071, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AEB071, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AEB071. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AEB071 experts. If you are a healthcare provider experienced in prescribing AEB071, please register here.
giCould not connect: